转移性阴茎状细胞癌对恩福图马布 (Enfortumab) 进行反应
Catherine C Fahey1,2, Caroline A Nebhan3, Sally York1,2,4
1Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
International journal of molecular sciences
|November 25, 2023
概括
转移性阴茎状细胞癌是一种罕见的癌症,通过使用恩福图马布-维多丁 (EV),Nectin-4抑制剂显著改善. 这种抗体-药物结合剂为晚期病例提供了一个有前途的新治疗方案.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 阴茎状细胞癌是罕见的,对转移性疾病的治疗选择有限.
- 晚期阴茎癌的有效疗法很少,需要新的方法.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...